tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BAYRY Stock Latest News

Bayer’s Prostate Cancer Study: Insights on Medication Adherence and Market Impact
Company AnnouncementsBayer’s Prostate Cancer Study: Insights on Medication Adherence and Market Impact
1d ago
Bayer’s Latest Clinical Study on Prostate Cancer Treatment: Key Insights for Investors
PremiumCompany Announcements
Bayer’s Latest Clinical Study on Prostate Cancer Treatment: Key Insights for Investors
1d ago
Bayer AG’s Observational Study on Vericiguat: Real-World Insights into Heart Failure Treatment
PremiumCompany Announcements
Bayer AG’s Observational Study on Vericiguat: Real-World Insights into Heart Failure Treatment
4d ago
Bayer’s FINE-REAL Study: Real-World Insights into Finerenone Use
PremiumCompany Announcements
Bayer’s FINE-REAL Study: Real-World Insights into Finerenone Use
4d ago
Bayer’s Aficamten Study: A New Hope for oHCM Treatment
PremiumCompany Announcements
Bayer’s Aficamten Study: A New Hope for oHCM Treatment
4d ago
Bayer’s Asundexian Study: A Potential Game-Changer in Stroke Prevention
PremiumCompany AnnouncementsBayer’s Asundexian Study: A Potential Game-Changer in Stroke Prevention
4d ago
Bayer’s Finerenone Trial: A Potential Game-Changer for Chronic Kidney Disease
Premium
Company Announcements
Bayer’s Finerenone Trial: A Potential Game-Changer for Chronic Kidney Disease
4d ago
Bayer’s New Study on Mirena: A Potential Game-Changer for Endometrial Hyperplasia Treatment
Premium
Company Announcements
Bayer’s New Study on Mirena: A Potential Game-Changer for Endometrial Hyperplasia Treatment
4d ago
Bayer’s Observational Study on Aflibercept for Preterm Infants: A Potential Market Game-Changer
PremiumCompany Announcements
Bayer’s Observational Study on Aflibercept for Preterm Infants: A Potential Market Game-Changer
4d ago
Bayer’s New Hope for Prostate Cancer: A Closer Look at the BAY3546828 Study
PremiumCompany Announcements
Bayer’s New Hope for Prostate Cancer: A Closer Look at the BAY3546828 Study
4d ago
Bayer’s BAY2927088: A Potential Game-Changer in NSCLC Treatment
PremiumCompany Announcements
Bayer’s BAY2927088: A Potential Game-Changer in NSCLC Treatment
4d ago
Bayer AG’s Observational Study on Hemophilia A Treatment: A Market Insight
PremiumCompany Announcements
Bayer AG’s Observational Study on Hemophilia A Treatment: A Market Insight
4d ago
Bayer’s FINEROD Study: Real-World Insights into Finerenone’s Impact on CKD and T2D
PremiumCompany AnnouncementsBayer’s FINEROD Study: Real-World Insights into Finerenone’s Impact on CKD and T2D
5d ago
Bayer AG’s Finerenone Study: A Potential Breakthrough in CKD Treatment for Type 1 Diabetes
Premium
Company Announcements
Bayer AG’s Finerenone Study: A Potential Breakthrough in CKD Treatment for Type 1 Diabetes
5d ago
Bayer’s Hemophilia A Study: Key Insights for Investors
Premium
Company Announcements
Bayer’s Hemophilia A Study: Key Insights for Investors
5d ago
Bayer’s Finerenone Study: A Potential Game-Changer for Chronic Kidney Disease
PremiumCompany Announcements
Bayer’s Finerenone Study: A Potential Game-Changer for Chronic Kidney Disease
5d ago
Bayer’s Kovaltry Study: Key Insights for Investors
PremiumCompany Announcements
Bayer’s Kovaltry Study: Key Insights for Investors
5d ago
Bayer’s Jivi Study: Long-term Safety Insights for Hemophilia A Treatment
PremiumCompany Announcements
Bayer’s Jivi Study: Long-term Safety Insights for Hemophilia A Treatment
5d ago
Bayer’s Darolutamide Study: Real-World Insights into Prostate Cancer Treatment
PremiumCompany Announcements
Bayer’s Darolutamide Study: Real-World Insights into Prostate Cancer Treatment
5d ago
Bayer’s Finerenone Study: A Potential Breakthrough in Non-Diabetic CKD Treatment
PremiumCompany AnnouncementsBayer’s Finerenone Study: A Potential Breakthrough in Non-Diabetic CKD Treatment
6d ago
Bayer AG’s New Study on Vericiguat: A Potential Game-Changer for Heart Failure Treatment
Premium
Company Announcements
Bayer AG’s New Study on Vericiguat: A Potential Game-Changer for Heart Failure Treatment
6d ago
Bayer AG’s Asundexian Study: A Potential Game-Changer in Stroke Prevention
Premium
Company Announcements
Bayer AG’s Asundexian Study: A Potential Game-Changer in Stroke Prevention
6d ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >